Vaccine COVID-19 February 24, 2022 Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine Read more
Vaccine COVID-19 December 16, 2021 Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate Read more
Vaccine COVID-19 December 7, 2021 Medicago and GSK announce positive Phase 3 efficacy and safety results for adjuvanted plant-based COVID-19 vaccine candidate Read more
Vaccine Clinical trials COVID-19 October 1, 2021 Medicago to launch clinical trials for COVID-19 vaccine candidate with GSK’s pandemic adjuvant in Japan Read more
Vaccine Clinical trials COVID-19 May 18, 2021 Medicago and GSK announce positive interim phase 2 results for adjuvanted COVID-19 vaccine candidate Read more
Vaccine COVID-19 April 23, 2021 Health Canada initiates the review of the rolling submission for the first canadian-based COVID-19 vaccine candidate Read more
Vaccine Clinical trials COVID-19 March 16, 2021 Medicago and GSK start phase 3 trial of adjuvanted COVID-19 vaccine candidate Read more
Vaccine Clinical trials COVID-19 November 12, 2020 Medicago and GSK announce start of phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate Read more
Vaccine Clinical trials COVID-19 November 10, 2020 Medicago announces positive phase 1 results for its COVID-19 vaccine candidate Read more
Corpo Vaccine COVID-19 October 23, 2020 Medicago signs agreements with the government of Canada to supply up to 76 million doses of its recombinant plant-derived COVID-19 vaccine Read more
Vaccine Clinical trials COVID-19 July 14, 2020 Medicago begins phase 1 clinical trials for its COVID-19 vaccine candidate Read more
Vaccine COVID-19 July 8, 2020 Dynavax and Medicago announce collaboration to develop a novel adjuvanted COVID-19 vaccine candidate Read more